Callisto Pharmaceuticals, Inc.

Callisto Pharmaceuticals, Inc., is a publicly traded biotechnology company on the American Stock Exchange (AMEX:KAL) and Frankfurt Exchange (CA4). Callisto's primary focus is the clinical development of two drugs to treat cancer, L-Annamycin for relapsed leukemia and Atiprimod for relapsed multiple myeloma (MM) and bone resorption. L-Annamycin, a drug from the anthracycline family, earlier completed a Phase I/IIa trial in refractory leukemia patients. Callisto recently initiated a new Phase I/II trial in relapsed leukemia patients on December 1, 2005. Callisto's second drug, Atiprimod, a small-molecule, orally available drug with antiproliferative and antiangiogenic activity, began an open-label Phase I/IIa clinical trial in relapsed MM patients on May 25, 2004. Atiprimod was recently the subject of two presentations and a poster at the American Society of Hematology ("ASH") Conference, held in Atlanta, GA, December 10-13, 2005. One of the presentations, by a researcher at M.D. Anderson Cancer Center, discussed data from the Atiprimod trial in mulitple myeloma patients and the other, by a researcher at Dana-Farber Cancer Institute, discussed a novel SCID-Hu mouse model of the disease.

Contact Details: 420 Lexington Avenue, Suite # 1609 New York New York 10170 United States of America Tel: 212-297-0010 Fax: 212-297-0020 Email: Jacob@callistopharma.com WWW: www.callistopharma.com/

Loading...

BioNews Results for Callisto Pharmaceuticals, Inc.:
Callisto Pharmaceuticals Inc-Detailed Product Pipeline - research report released	PR inside:  Nov 3 2009 7:46AM Matching: callisto pharmaceuticals inc
Callisto Pharmaceuticals Inc-Financial Company Report - research report released	PR inside:  Oct 30 2009 5:09PM Matching: callisto pharmaceuticals inc
Callisto Pharmaceuticals, Inc.-Deals & Alliances Report - research report released	PR inside:  Oct 28 2009 6:40PM Matching: callisto pharmaceuticals inc
Synergy Pharmaceuticals to Present at the 17th Annual BioPartnering Europe Conference in London, UK	Pharma Live:  Oct 6 2009 2:38AM Matching: callisto pharmaceuticals inc

Callisto Pharmaceuticals, Inc. (KAL) Financial information Links from Barchart
KAL Quote from from Barchart.com
KAL Chart from from Barchart.com
KAL Profile from from Barchart.com
KAL Opinion from from Barchart.com
→View more Callisto Pharmaceuticals, Inc. finance information.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 329 times since April 2007, the link to the organisation's website has been followed 47 times

Search for more companies in New York

Search for more companies in New York

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Callisto Pharmaceuticals, Inc.